Low-Density Lipoprotein Cholesterol as a Protective Factor in COPD and Implications for Statin Therapy: A Multi-Omics Genetic Epidemiology Study.

Abstract excerpt

Background: Chronic obstructive pulmonary disease (COPD) is a complex lung condition primarily affecting the airways and alveoli, characterized by persistent progressive airflow limitation. COPD ranks as the third leading cause of death worldwide, with its incidence and mortality rates escalating annually due to an aging population. This study aimed to explore the association between low-density lipoprotein...

Topics

Join the communities discussing this publication.

• Cholesterol, LDL
• Disease Progression
• Dyslipidemias
• Hydroxymethylglutaryl-CoA Reductase Inhibitors
• Molecular Epidemiology